Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line
Authors:
- 1 April 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (9) , 1701-1704
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Down-regulation of transforming growth factor-α by tamoxifen in human breast cancerCancer, 1993
- Effect of P-glycoprotein Expression on Sensitivity to Hormones in MCF-7 Human Breast Cancer CellsJNCI: Journal of the National Cancer Institute, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 CellsAmerican Journal of Clinical Oncology, 1991
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- [24] Assay and purification of protein kinase C1986
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976